Malin Corporation | MLC - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 7M 2M 2026-03
ALKERMES USD 5.88B 1.26B 2026-03
Avita Medical AUD 105.47M 35.32M 2025-12
Dianthus Therapeutics USD 2.71B 1.87B 2026-07
Eurofins Scientific SE EUR 11.37B 357.04M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
IQVIA Holdings USD 28.63B 9.76B 2026-03
Lonza CHF 39.68B 980.61M 2025-06
Malin Corporation EUR 142.92M 19.65M 2026-02
Moderna USD 20.15B 8.53B 2026-03
Organon & Co USD 3.47B 1.9B 2026-07
Ovoca Bio EUR 6.12M 4.93M 2026-04
Revvity USD 9.94B 1.03B 2026-03
Tectonic Therapeutic USD 510M 70M 2026-07
Viatris USD 15.73B 1.39B 2026-03
Xeris Pharmaceuticals USD 1.11B 112M 2026-07